Does Rallies show Form 4 insider transactions for AZTR?

Yes. Rallies tracks AZTR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is AZTR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AZTR. It does not provide personalized investment advice.

AZTR (Azitra Inc) Stock Analysis - Insider Trades

Azitra Inc (AZTR) is a publicly traded Healthcare sector company. As of May 21, 2026, AZTR trades at $0.20 with a market cap of $3.08M and a P/E ratio of -0.09. AZTR moved +3.68% today. Year to date, AZTR is -30.56%; over the trailing twelve months it is -89.97%. Its 52-week range spans $0.10 to $4.33. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces AZTR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading AZTR stock inside the company?

Recent AZTR insider activity includes Staskey Norm bought 47.60K, Whitfill Travis bought 15.00K, Staskey Norm bought 3.30K, Salva Francisco D. bought 333.30K, and Kreis Leslie W. bought 69.88K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

AZTR Key Metrics

Key financial metrics for AZTR
Metric	Value
Price	$0.20
Market Cap	$3.08M
P/E Ratio	-0.09
EPS	$-2.25
Dividend Yield	0.00%
52-Week High	$4.33
52-Week Low	$0.10
Volume	2.75K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.96M
Gross Margin	0.00%

Recent AZTR Insider Trades

Staskey Norm bought 47.60K (~$10.03K) on Mar 29, 2024.
Whitfill Travis bought 15.00K (~$4.50K) on Feb 13, 2024.
Staskey Norm bought 3.30K (~$990) on Feb 13, 2024.
Salva Francisco D. bought 333.30K (~$99.99K) on Feb 13, 2024.
Kreis Leslie W. bought 69.88K (~$349.40K) on Jun 21, 2023.

Latest AZTR News

Azitra Raises $10.5 M, Adds MD Anderson Site, Secures ATR-12 Patent — May 13, 2026
Azitra Secures U.S. Patent No. 12,606,610 B2 for ATR-12 Phase 1b Netherton Syndrome Therapy — May 6, 2026
Azitra’s ATR01-616 Cuts TEWL (p<0.001) and Restores Skin Barrier Preclinically — Apr 28, 2026
Azitra Secures $10.5M Private Placement, Potential Additional $20.9M for Cosmetic Programs — Mar 19, 2026
Azitra Given NYSE Notice for $6M Equity Shortfall, Faces April 2027 Deadline — Mar 13, 2026

AZTR Analyst Consensus

1 analysts cover AZTR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.

Common questions about AZTR

Who is trading AZTR stock inside the company?: Recent AZTR insider activity includes Staskey Norm bought 47.60K, Whitfill Travis bought 15.00K, Staskey Norm bought 3.30K, Salva Francisco D. bought 333.30K, and Kreis Leslie W. bought 69.88K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AZTR?: Yes. Rallies tracks AZTR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AZTR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AZTR. It does not provide personalized investment advice.